I was thinking about this also, The statement from

I was thinking about this also, The statement from Nader that the FDA wants to see the raw data ASAP sounds great, but maybe there is a reason for it. What if it is an attempt by the FDA to somewhat control the news, good or bad?Maybe this takes away the pressure on the FDA to act fast, they might look at the data and have piles of questions/comments that slow the process down. If we just put out a top line report publicly the FDA has to address it. The good thing is that we have the MHRA and the Philippines to put pressure on. IF the FDA drags there feet we could just go elsewhere.

One thing for sure, the drug must work, the doctors on these calls see first hand the patient responses from the EIND and the trial. They would not be on that Philippine's call if it was a nothing burger.